ALBPSBiophytisALBPS info
$0.50info1.10%24h
Global rank11596
Market cap$486.82M
Change 7d-
YTD Performance8721.57%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Biophytis (ALBPS) Stock Overview

    Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

    ALBPS Stock Information

    Symbol
    ALBPS
    Address
    Sorbonne UniversityParis, 75005France
    Founded
    -
    Trading hours
    -
    Website
    https://www.biophytis.com
    Country
    🇫🇷 France
    Phone Number
    33 1 44 27 23 00

    Biophytis (ALBPS) Price Chart

    -
    Value:-

    Biophytis Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.5000555740802489
    N/A
    Market Cap
    $486.82M
    N/A
    Shares Outstanding
    973.52M
    N/A
    Employees
    26.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org